img

Global GLP Analogs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global GLP Analogs Market Insights, Forecast to 2034

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
Global GLP Analogs market is expected to reach to US$ 5710 million in 2024, with a positive growth of %, compared with US$ 5387 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, GLP Analogs industry is evaluated to reach US$ 7350.9 million in 2029. The CAGR will be 4.3% during 2024 to 2029.
The Glucagon-like peptide 1 (GLP-1) market is driven by the increasing prevalence of diabetes and the growing demand for effective and innovative diabetes treatments. GLP-1 is a hormone that plays a crucial role in regulating blood sugar levels and is used in the treatment of type 2 diabetes. The rise in the number of diabetic patients and the need for better glycemic control contribute to market growth as GLP-1-based therapies offer significant benefits, including glucose-lowering effects and weight management. Moreover, advancements in GLP-1 analog formulations, such as long-acting and once-weekly options, have improved patient compliance and treatment outcomes. However, the market also faces challenges, including the cost of GLP-1 treatments and the need for further research to optimize dosing and combination therapies. Additionally, addressing the barriers to GLP-1 adoption, such as injection-related fears, can pose obstacles for broader market penetration. To succeed, companies must focus on research and development to offer innovative and cost-effective GLP-1 therapies, collaborate with healthcare providers to optimize treatment regimens, and address the challenges to meet the increasing demand for effective and well-tolerated diabetes treatments based on GLP-1.
Report Covers
This report presents an overview of global GLP Analogs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global GLP Analogs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
Segment by Type
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide

Segment by Application


Hospital
Pharmacy
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ GLP Analogs plant distribution, commercial date of GLP Analogs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, GLP Analogs introduction, etc. GLP Analogs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of GLP Analogs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 GLP Analogs Product Introduction
1.2 Market by Type
1.2.1 Global GLP Analogs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Dulaglutide
1.3 Market by Application
1.3.1 Global GLP Analogs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global GLP Analogs Sales Estimates and Forecasts 2018-2029
2.2 Global GLP Analogs Revenue by Region
2.2.1 Global GLP Analogs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global GLP Analogs Revenue by Region (2018-2024)
2.2.3 Global GLP Analogs Revenue by Region (2024-2029)
2.2.4 Global GLP Analogs Revenue Market Share by Region (2018-2029)
2.3 Global GLP Analogs Sales Estimates and Forecasts 2018-2029
2.4 Global GLP Analogs Sales by Region
2.4.1 Global GLP Analogs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global GLP Analogs Sales by Region (2018-2024)
2.4.3 Global GLP Analogs Sales by Region (2024-2029)
2.4.4 Global GLP Analogs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global GLP Analogs Sales by Manufacturers
3.1.1 Global GLP Analogs Sales by Manufacturers (2018-2024)
3.1.2 Global GLP Analogs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of GLP Analogs in 2022
3.2 Global GLP Analogs Revenue by Manufacturers
3.2.1 Global GLP Analogs Revenue by Manufacturers (2018-2024)
3.2.2 Global GLP Analogs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by GLP Analogs Revenue in 2022
3.3 Global Key Players of GLP Analogs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global GLP Analogs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global GLP Analogs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of GLP Analogs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of GLP Analogs, Product Offered and Application
3.8 Global Key Manufacturers of GLP Analogs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global GLP Analogs Sales by Type
4.1.1 Global GLP Analogs Historical Sales by Type (2018-2024)
4.1.2 Global GLP Analogs Forecasted Sales by Type (2024-2029)
4.1.3 Global GLP Analogs Sales Market Share by Type (2018-2029)
4.2 Global GLP Analogs Revenue by Type
4.2.1 Global GLP Analogs Historical Revenue by Type (2018-2024)
4.2.2 Global GLP Analogs Forecasted Revenue by Type (2024-2029)
4.2.3 Global GLP Analogs Revenue Market Share by Type (2018-2029)
4.3 Global GLP Analogs Price by Type
4.3.1 Global GLP Analogs Price by Type (2018-2024)
4.3.2 Global GLP Analogs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global GLP Analogs Sales by Application
5.1.1 Global GLP Analogs Historical Sales by Application (2018-2024)
5.1.2 Global GLP Analogs Forecasted Sales by Application (2024-2029)
5.1.3 Global GLP Analogs Sales Market Share by Application (2018-2029)
5.2 Global GLP Analogs Revenue by Application
5.2.1 Global GLP Analogs Historical Revenue by Application (2018-2024)
5.2.2 Global GLP Analogs Forecasted Revenue by Application (2024-2029)
5.2.3 Global GLP Analogs Revenue Market Share by Application (2018-2029)
5.3 Global GLP Analogs Price by Application
5.3.1 Global GLP Analogs Price by Application (2018-2024)
5.3.2 Global GLP Analogs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada GLP Analogs Market Size by Type
6.1.1 US & Canada GLP Analogs Sales by Type (2018-2029)
6.1.2 US & Canada GLP Analogs Revenue by Type (2018-2029)
6.2 US & Canada GLP Analogs Market Size by Application
6.2.1 US & Canada GLP Analogs Sales by Application (2018-2029)
6.2.2 US & Canada GLP Analogs Revenue by Application (2018-2029)
6.3 US & Canada GLP Analogs Market Size by Country
6.3.1 US & Canada GLP Analogs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada GLP Analogs Sales by Country (2018-2029)
6.3.3 US & Canada GLP Analogs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe GLP Analogs Market Size by Type
7.1.1 Europe GLP Analogs Sales by Type (2018-2029)
7.1.2 Europe GLP Analogs Revenue by Type (2018-2029)
7.2 Europe GLP Analogs Market Size by Application
7.2.1 Europe GLP Analogs Sales by Application (2018-2029)
7.2.2 Europe GLP Analogs Revenue by Application (2018-2029)
7.3 Europe GLP Analogs Market Size by Country
7.3.1 Europe GLP Analogs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe GLP Analogs Sales by Country (2018-2029)
7.3.3 Europe GLP Analogs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China GLP Analogs Market Size
8.1.1 China GLP Analogs Sales (2018-2029)
8.1.2 China GLP Analogs Revenue (2018-2029)
8.2 China GLP Analogs Market Size by Application
8.2.1 China GLP Analogs Sales by Application (2018-2029)
8.2.2 China GLP Analogs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia GLP Analogs Market Size by Type
9.1.1 Asia GLP Analogs Sales by Type (2018-2029)
9.1.2 Asia GLP Analogs Revenue by Type (2018-2029)
9.2 Asia GLP Analogs Market Size by Application
9.2.1 Asia GLP Analogs Sales by Application (2018-2029)
9.2.2 Asia GLP Analogs Revenue by Application (2018-2029)
9.3 Asia GLP Analogs Sales by Region
9.3.1 Asia GLP Analogs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia GLP Analogs Revenue by Region (2018-2029)
9.3.3 Asia GLP Analogs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America GLP Analogs Market Size by Type
10.1.1 Middle East, Africa and Latin America GLP Analogs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America GLP Analogs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America GLP Analogs Market Size by Application
10.2.1 Middle East, Africa and Latin America GLP Analogs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America GLP Analogs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America GLP Analogs Sales by Country
10.3.1 Middle East, Africa and Latin America GLP Analogs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America GLP Analogs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America GLP Analogs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk GLP Analogs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novo Nordisk GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca GLP Analogs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AstraZeneca GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Eli Lily
11.3.1 Eli Lily Company Information
11.3.2 Eli Lily Overview
11.3.3 Eli Lily GLP Analogs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Eli Lily GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lily Recent Developments
11.4 GSK
11.4.1 GSK Company Information
11.4.2 GSK Overview
11.4.3 GSK GLP Analogs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 GSK GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GSK Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi GLP Analogs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Sanofi GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Overview
11.6.3 Bristol-Myers Squibb GLP Analogs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Bristol-Myers Squibb GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Amylin
11.7.1 Amylin Company Information
11.7.2 Amylin Overview
11.7.3 Amylin GLP Analogs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Amylin GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Amylin Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 GLP Analogs Industry Chain Analysis
12.2 GLP Analogs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 GLP Analogs Production Mode & Process
12.4 GLP Analogs Sales and Marketing
12.4.1 GLP Analogs Sales Channels
12.4.2 GLP Analogs Distributors
12.5 GLP Analogs Customers
13 Market Dynamics
13.1 GLP Analogs Industry Trends
13.2 GLP Analogs Market Drivers
13.3 GLP Analogs Market Challenges
13.4 GLP Analogs Market Restraints
14 Key Findings in The Global GLP Analogs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global GLP Analogs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Exenatied
Table 3. Major Manufacturers of Liraglutide
Table 4. Major Manufacturers of Lixisenatide
Table 5. Major Manufacturers of Albiglutide
Table 6. Major Manufacturers of Dulaglutide
Table 7. Global GLP Analogs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global GLP Analogs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global GLP Analogs Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global GLP Analogs Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global GLP Analogs Revenue Market Share by Region (2018-2024)
Table 12. Global GLP Analogs Revenue Market Share by Region (2024-2029)
Table 13. Global GLP Analogs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global GLP Analogs Sales by Region (2018-2024) & (K Units)
Table 15. Global GLP Analogs Sales by Region (2024-2029) & (K Units)
Table 16. Global GLP Analogs Sales Market Share by Region (2018-2024)
Table 17. Global GLP Analogs Sales Market Share by Region (2024-2029)
Table 18. Global GLP Analogs Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global GLP Analogs Sales Share by Manufacturers (2018-2024)
Table 20. Global GLP Analogs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global GLP Analogs Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of GLP Analogs, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. GLP Analogs Price by Manufacturers 2018-2024 (USD/Unit)
Table 24. Global GLP Analogs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global GLP Analogs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP Analogs as of 2022)
Table 26. Global Key Manufacturers of GLP Analogs, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of GLP Analogs, Product Offered and Application
Table 28. Global Key Manufacturers of GLP Analogs, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global GLP Analogs Sales by Type (2018-2024) & (K Units)
Table 31. Global GLP Analogs Sales by Type (2024-2029) & (K Units)
Table 32. Global GLP Analogs Sales Share by Type (2018-2024)
Table 33. Global GLP Analogs Sales Share by Type (2024-2029)
Table 34. Global GLP Analogs Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global GLP Analogs Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global GLP Analogs Revenue Share by Type (2018-2024)
Table 37. Global GLP Analogs Revenue Share by Type (2024-2029)
Table 38. GLP Analogs Price by Type (2018-2024) & (USD/Unit)
Table 39. Global GLP Analogs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 40. Global GLP Analogs Sales by Application (2018-2024) & (K Units)
Table 41. Global GLP Analogs Sales by Application (2024-2029) & (K Units)
Table 42. Global GLP Analogs Sales Share by Application (2018-2024)
Table 43. Global GLP Analogs Sales Share by Application (2024-2029)
Table 44. Global GLP Analogs Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global GLP Analogs Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global GLP Analogs Revenue Share by Application (2018-2024)
Table 47. Global GLP Analogs Revenue Share by Application (2024-2029)
Table 48. GLP Analogs Price by Application (2018-2024) & (USD/Unit)
Table 49. Global GLP Analogs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 50. US & Canada GLP Analogs Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada GLP Analogs Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada GLP Analogs Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada GLP Analogs Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada GLP Analogs Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada GLP Analogs Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada GLP Analogs Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada GLP Analogs Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada GLP Analogs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada GLP Analogs Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada GLP Analogs Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada GLP Analogs Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada GLP Analogs Sales by Country (2024-2029) & (K Units)
Table 63. Europe GLP Analogs Sales by Type (2018-2024) & (K Units)
Table 64. Europe GLP Analogs Sales by Type (2024-2029) & (K Units)
Table 65. Europe GLP Analogs Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe GLP Analogs Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe GLP Analogs Sales by Application (2018-2024) & (K Units)
Table 68. Europe GLP Analogs Sales by Application (2024-2029) & (K Units)
Table 69. Europe GLP Analogs Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe GLP Analogs Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe GLP Analogs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe GLP Analogs Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe GLP Analogs Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe GLP Analogs Sales by Country (2018-2024) & (K Units)
Table 75. Europe GLP Analogs Sales by Country (2024-2029) & (K Units)
Table 76. China GLP Analogs Sales by Type (2018-2024) & (K Units)
Table 77. China GLP Analogs Sales by Type (2024-2029) & (K Units)
Table 78. China GLP Analogs Revenue by Type (2018-2024) & (US$ Million)
Table 79. China GLP Analogs Revenue by Type (2024-2029) & (US$ Million)
Table 80. China GLP Analogs Sales by Application (2018-2024) & (K Units)
Table 81. China GLP Analogs Sales by Application (2024-2029) & (K Units)
Table 82. China GLP Analogs Revenue by Application (2018-2024) & (US$ Million)
Table 83. China GLP Analogs Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia GLP Analogs Sales by Type (2018-2024) & (K Units)
Table 85. Asia GLP Analogs Sales by Type (2024-2029) & (K Units)
Table 86. Asia GLP Analogs Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia GLP Analogs Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia GLP Analogs Sales by Application (2018-2024) & (K Units)
Table 89. Asia GLP Analogs Sales by Application (2024-2029) & (K Units)
Table 90. Asia GLP Analogs Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia GLP Analogs Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia GLP Analogs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia GLP Analogs Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia GLP Analogs Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia GLP Analogs Sales by Region (2018-2024) & (K Units)
Table 96. Asia GLP Analogs Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America GLP Analogs Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America GLP Analogs Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America GLP Analogs Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America GLP Analogs Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America GLP Analogs Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America GLP Analogs Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America GLP Analogs Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America GLP Analogs Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America GLP Analogs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America GLP Analogs Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America GLP Analogs Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America GLP Analogs Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America GLP Analogs Sales by Country (2024-2029) & (K Units)
Table 110. Novo Nordisk Company Information
Table 111. Novo Nordisk Description and Major Businesses
Table 112. Novo Nordisk GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Novo Nordisk GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Novo Nordisk Recent Developments
Table 115. AstraZeneca Company Information
Table 116. AstraZeneca Description and Major Businesses
Table 117. AstraZeneca GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. AstraZeneca GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. AstraZeneca Recent Developments
Table 120. Eli Lily Company Information
Table 121. Eli Lily Description and Major Businesses
Table 122. Eli Lily GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Eli Lily GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Eli Lily Recent Developments
Table 125. GSK Company Information
Table 126. GSK Description and Major Businesses
Table 127. GSK GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. GSK GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. GSK Recent Developments
Table 130. Sanofi Company Information
Table 131. Sanofi Description and Major Businesses
Table 132. Sanofi GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Sanofi GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sanofi Recent Developments
Table 135. Bristol-Myers Squibb Company Information
Table 136. Bristol-Myers Squibb Description and Major Businesses
Table 137. Bristol-Myers Squibb GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Bristol-Myers Squibb GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Bristol-Myers Squibb Recent Developments
Table 140. Amylin Company Information
Table 141. Amylin Description and Major Businesses
Table 142. Amylin GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Amylin GLP Analogs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Amylin Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. GLP Analogs Distributors List
Table 148. GLP Analogs Customers List
Table 149. GLP Analogs Market Trends
Table 150. GLP Analogs Market Drivers
Table 151. GLP Analogs Market Challenges
Table 152. GLP Analogs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. GLP Analogs Product Picture
Figure 2. Global GLP Analogs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global GLP Analogs Market Share by Type in 2022 & 2029
Figure 4. Exenatied Product Picture
Figure 5. Liraglutide Product Picture
Figure 6. Lixisenatide Product Picture
Figure 7. Albiglutide Product Picture
Figure 8. Dulaglutide Product Picture
Figure 9. Global GLP Analogs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global GLP Analogs Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Pharmacy
Figure 13. Other
Figure 14. GLP Analogs Report Years Considered
Figure 15. Global GLP Analogs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global GLP Analogs Revenue 2018-2029 (US$ Million)
Figure 17. Global GLP Analogs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global GLP Analogs Revenue Market Share by Region (2018-2029)
Figure 19. Global GLP Analogs Sales 2018-2029 ((K Units)
Figure 20. Global GLP Analogs Sales Market Share by Region (2018-2029)
Figure 21. US & Canada GLP Analogs Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada GLP Analogs Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe GLP Analogs Sales YoY (2018-2029) & (K Units)
Figure 24. Europe GLP Analogs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China GLP Analogs Sales YoY (2018-2029) & (K Units)
Figure 26. China GLP Analogs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) GLP Analogs Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) GLP Analogs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America GLP Analogs Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America GLP Analogs Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The GLP Analogs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of GLP Analogs in the World: Market Share by GLP Analogs Revenue in 2022
Figure 33. Global GLP Analogs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global GLP Analogs Sales Market Share by Type (2018-2029)
Figure 35. Global GLP Analogs Revenue Market Share by Type (2018-2029)
Figure 36. Global GLP Analogs Sales Market Share by Application (2018-2029)
Figure 37. Global GLP Analogs Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada GLP Analogs Sales Market Share by Type (2018-2029)
Figure 39. US & Canada GLP Analogs Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada GLP Analogs Sales Market Share by Application (2018-2029)
Figure 41. US & Canada GLP Analogs Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada GLP Analogs Revenue Share by Country (2018-2029)
Figure 43. US & Canada GLP Analogs Sales Share by Country (2018-2029)
Figure 44. U.S. GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 45. Canada GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 46. Europe GLP Analogs Sales Market Share by Type (2018-2029)
Figure 47. Europe GLP Analogs Revenue Market Share by Type (2018-2029)
Figure 48. Europe GLP Analogs Sales Market Share by Application (2018-2029)
Figure 49. Europe GLP Analogs Revenue Market Share by Application (2018-2029)
Figure 50. Europe GLP Analogs Revenue Share by Country (2018-2029)
Figure 51. Europe GLP Analogs Sales Share by Country (2018-2029)
Figure 52. Germany GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 53. France GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 55. Italy GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 56. Russia GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 57. China GLP Analogs Sales Market Share by Type (2018-2029)
Figure 58. China GLP Analogs Revenue Market Share by Type (2018-2029)
Figure 59. China GLP Analogs Sales Market Share by Application (2018-2029)
Figure 60. China GLP Analogs Revenue Market Share by Application (2018-2029)
Figure 61. Asia GLP Analogs Sales Market Share by Type (2018-2029)
Figure 62. Asia GLP Analogs Revenue Market Share by Type (2018-2029)
Figure 63. Asia GLP Analogs Sales Market Share by Application (2018-2029)
Figure 64. Asia GLP Analogs Revenue Market Share by Application (2018-2029)
Figure 65. Asia GLP Analogs Revenue Share by Region (2018-2029)
Figure 66. Asia GLP Analogs Sales Share by Region (2018-2029)
Figure 67. Japan GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 71. India GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America GLP Analogs Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America GLP Analogs Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America GLP Analogs Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America GLP Analogs Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America GLP Analogs Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America GLP Analogs Sales Share by Country (2018-2029)
Figure 78. Brazil GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 81. Israel GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries GLP Analogs Revenue (2018-2029) & (US$ Million)
Figure 83. GLP Analogs Value Chain
Figure 84. GLP Analogs Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed